“Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer”, J. Can. Res. Updates, vol. 11, pp. 63–69, Oct. 2022, doi: 10.30683/1929-2279.2022.11.09.